Bharat Biotech Limited Current Affairs - 2020

COVISHIELD: India to take up clinical trials of OXFORD Vaccine

On July 26, 2020, Central Drugs Standard Control Organization announced that it will take up clinical trials of COVID-19 vaccine, COVISHIELD developed by Oxford University and AstraZeneca. Highlights The trials are being considered by CDSCO after the request from Serum Institute of India. The phase III of the trials is to be conducted in India. Read More…

Zydus Healthcare’s COVID-19 vaccine gets DCGI approval for Human Clinical Trials

On 2nd July 2020, the Drug Controller General of India (DCGI) has given approval for human clinical trials to Ahmedabad based Cadila Healthcare Limited (Zydus Healthcare). The permission is for the Phase-I and Phase-II clinical trials of the vaccine. Zydus Healthcare’s COVID-19 vaccine become the 2nd Indigenously developed vaccine to get the permission of the Read More…

ICMR fast-tracking efforts to launch ‘COVAXIN’ for public use by 15th August

In partnership with Hyderabad based Bharat Biotech, the Indian Council of Medical Research (ICMR) has selected 12 institutes for the Phase-I and Phase-II clinical trials of the first indigenously developed COVID-19 vaccine BBV152 (commonly known as COVAXIN). After successful completion of human clinical trials, the ICMR has set a target to launch the COVAXIN for Read More…

RMRC Dibrugarh becomes the 4th Laboratory in India to isolate COVID-19 Virus Strain

The Indian Council of Medical Research’s (ICMR’s) regional centre at Assam’s Dibrugarh- Regional Medical Research Centre (RMRC) has successfully able to isolate the SARS-CoV-2 (COVID-19) virus strain. This success will open up avenues to conduct COVID-19 related studies such as from the development of a potential vaccine to making other uses of cultures of the Read More…

Indigenously Developed ‘COVAXIN’ gets DCGI approval for Human Clinical Trials

The Drug Controller General of India (DCGI) has given approval for Phase I and Phase II human clinical trials for COVID-19 vaccine ‘COVAXIN’. In association with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), COVAXIN is developed by Hyderabad based vaccine & bio-therapeutics manufacturer-Bharat Biotech.  At NIV Pune, the Read More…